Critical determinants of melanoma metastasis

Journal of Investigative Dermatology Symposium Proceedings

Volumn 1, Issue 2, 1996, Pages 203-208

  Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN;

ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; BRAIN TUMOR; HUMAN; MELANOMA; METASTASIS; MOUSE; PHENOTYPE; REVIEW;

ANIMALS; BRAIN NEOPLASMS; HUMANS; MELANINS; MELANOMA; MICE; ORGAN SPECIFICITY; PHENOTYPE;

EID: 0030112281     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Akslen LA, Hove LM, Hartveit F: Metastatic distribution in malignant melanoma. A 30-year autopsy study. Invasion Metastasis 7:253-263, 1987
2. Aukerman SL, Price JE, Fidler IJ: Different deficiencies in the prevention of tumorigenic-Iow-me ta static murine K-1735 melanoma cells from producing métastases. J Hatl Cancer Inst 77:915-924, 1986
3. Balch CM, Cascinelli N, Milton GW, Sim FH: Surgical decisions regarding lymph node dissection for stage I melanoma patients: pros and cons of immediate vs. delayed lymphadenectomy. In: Balch CM, Milton GW (eds.). Cutaneous Melanoma: Clinifal Management and Treatment Results Worldmde. JB Lippincott, Philadelphia, 1985, pp 188-200
4. Benedict WF, Murphree AL, Benerjee A, Spina CA, Sparkes MC, Sparkes RC: Patient with 13 chromosome deletions: evidence that the retinoblastoma gene is a recessive cancer gene. Science 219:976-978, 1983
5. Bishop JM; The molecular genetics of cancer. Science 235:305-311, 1987
6. Chhajlani V, Wiberg JES; Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEES Lett 3:417-420, 1992
7. DeBaetselier P, Gorelic E, Eshar Z, Ron Y, Katzav S, Feldman M, Segal S: Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen Blymphocytes with plasmocytoma cells. J Natl Cancer Inst 67:1079-1087, 1981
8. Dong Z, Radinsky R, Fan D, Tsan R, Bucana CD, WUmanns C, Fidler IJ: Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells. J Natl Cancer Inst 86:913-920, 1994
9. Fabra A, Nakajima M, Bucana CD, Fidler IJ: Modulation of the invasive phenotype of human colon carcinoma cells by nbroblasts from ortbotopic or ectopic organs of nude mice. Differentiation 52:101-110, 1992
10. Fidler IJ: Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo-2'-deoxyuridine. J Nail Cancer Inst 45:773-782, 1970
11. Fidler IJ: The biology of melanoma metastasis. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S (eds.). Cutaneous Melanoma. 2nd ed. JB Lippincott, Philadelphia, 1992, pp 112-129
12. Fidler IJ: Cancer biology: invasion and metastasis. In: Abeloff MD, Armitage JO, Lichter AS, Nïederhuber JE (eds.). Clinical Oncology. Churchill Livingstone, New York, 1995, pp 55-76
13. Fidler IJ, Gruys E, Cîfone MA, Barnes Z, Bucana CD: Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J Natl Cancer Inst 67:947-956, 1981
14. Fidler IJ, Hart IR: Biological diversity in metastatic neoplasms: origins and implications. Sciettce 217:998-1003, 1982
15. Fidler IJ, Kripke ML: Metastasis results from pre-existing variant cells within a malignant tumor. Science 197:893-895, 1977
16. Fidler IJ, Nicolson GL: Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. J Natl Cancer Inst 57:1199-1202, 1976
17. Fidler IJ, Radinsky R: Genetic control of cancer metastasis (editorial). J Naff Cancer Inst 82:166-168, 1990
18. Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res 46:467-473, 1986
19. Folkman J, Klagsburn M: Angiogenic factors. Science 235:444-447, 1987
20. Fujimaki T, Fan D, Staroselsky AH, Gohji K, Bucana CD, Fidler IJ: Critical factors regulating site-specific brain metastasis of murine melanomas. Int J Oncol 3:789-799. 1993
21. Harris H: Suppression of malignancy in hybrid cells: the mechanism. J Cell Sci 79:83-94, 1985
22. Hart IR: Seed and soil revisited: mechanisms of site-specific metastasis. Cancer Metastasis Rev 1:5-17, 1982
23. Hart IR, Fidler IJ: Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Confer Res 40:2281-2287, 1980
24. Hart IR, Goode NT, Wilson RE: Molecular aspects of the metastaric cascade. Bwchim Biophys Acta 989:65-84, 1989
25. Kripke ML: Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J Nail Confer Itist 67:947-956, 1981
26. Lagarde AE, Kerbel RS: Somatic cell hybridization I'M vivo and in vitro in relation to the metastatic phenotype. Biochim Biophys Acta 823:81-110, 1985
27. Larizza L, Schirrmacher V: Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants. Cancer Metastasis Rei' 3:192-222, 1984
28. Liotta LA: Gene products which play a role in cancer invasion and metastasis. Breast Cancer Res Treat 11:113-124, 1988
29. Lurïa SE, Delbruck M: Mutations of bacteria from virus sensitive to virus resistance. Genetics 28:491-511, 1943
30. Madjewicz ST, Karakousis C, West CR, Caracandas J, Avellanosa AM: Malignant melanoma brain métastases. Review of Roswell Park Memorial Institute experience. Cancer 53:2550-2565, 1984
31. Matsumura Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340:1053-1059, 1992
32. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD: The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248-1251, 1992
33. Nakajima M, Morikawa K, Fabra A, Ducana CD, Fidler IJ: Influence of the organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Notl Cancer Inst 82:1890-1898. 1990
34. Nicolson GL: Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res 47:1473-1487, 1987
35. Nicolson GL: Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary- sites. Bioehim Biophys Acta 948:175-224, 1988
36. Paget S: The distribution of secondary growths in cancer of the breast. Lancet 1:571-573, 1889
37. Poste G, Fidler IJ: The pathogenesis of cancer metastasis, Nature 283:139-146, 1980
38. Price JE, Aukerman SL, Fidler IJ: Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. Cancer Res 46:5172-5178, 1986
39. Price JE, Tarin D, Fidler IJ: The influence of organ microenvironment on pigmentation of a metastatic murine melanoma. Cattter Res 48:2258-2264, 1988
40. Radinsky R, Beltran PJ, Tsan R, Zhang R, Cone RD, Fidler IJ: Transcriptional induction of the melanocyte-stimulating hormone receptor in brain métastases of murine K-1735 melanoma. Cancer Res 55:141-148, 1995
41. Radinsky R, Fidler IJ, Price JE, Esumi N, Tsan R, Petty CM, Bucana CD, Bar-Eli M: Terminal differentiation and apoptosis in experimental lung métastases of human osteogenic sarcoma cells by wild-type p53. Oncogene 9:1877-1883, 1994
42. Ramshaw IA, Carlscn S, Wang HC, Badenoch-Jones P: The use of cell fusion to analyze factors involved in tumor cell metastasis. IntJ Cancer 32:471-478, 1983
43. Roos E, La Riviere G, Collard JG, Stukart MJ, DeBaetselier P: Invasiveness of T-cell hybridomas m vitro and their metastatic potential i vivo. Cancer Res 45:6238 -6243, 1985
44. Schackert G, Fidler IJ: Development off in vivo models for studies of brain metastasis. IntJ Cancer 41:589-594. 1988a
45. Schackert G, Fidler IJ: Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or the méninges of syngeneic animals. Cancer Res 48:3478-3484, 1988b
46. Schackert G, Price JE, Zhang RD, Bucana CD, Itoh K, Fidler IJ: Regional growth of different human melanomas as métastases in the brain of nude mice. AmJ Pathol 136:95-102, 1990
47. Shih C, Weinberg RA: Isolation of a transforming sequence from a human bladder cancer. Celt 29:161-169, 1982
48. Sidebottom E, Clark SR: Cell fusion segregates progressive growth from metastasis. Br J Cancer 47:399-406, 1983
49. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ: Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice, Cancer Res 54:3242-3247, 1994
50. Solca F, Siegrist W, Drozdz R, Girard J, Ebcrle AN: The receptor for a-melanotropin of mouse and human melanoma cells. J Biol Chetn 264:14277-14281, 1989
51. Stanbridge EG, Flandermeyer RR, Daniels DW, Nelson-Rees WA: Specific chromo-some loss associated with the expression of tumorigenicity in human cell hybrids. Somatic Cell Geiict 7:699-712, 1981
52. Staroselsky AH, Pathak S, Chernajovsky Y, Tucker SL, Fidler IJ: Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma. Cancer Res 51:6292-6298. 1991
53. Talmadge JE, Fidler IJ: Cancer metastasis is selective or random depending on the parent tumor population. Nature 27:593-594, 1982a
54. Talmadge JE, Fidler IJ: Enhanced metastatic potential of tumor cells harvested from spontaneous métastases of heterogeneous murine tumors. J Natl Cancer Inst 69:975-980, J982b
55. Talmadge JE, Wolman SR, Fidler IJ: Evidence for the clonal origin of spontaneous metastasis. Sciettee 217:361-363. 1982
56. Tarin D, Price JE, Kettlewell MOW, Souter RG, Vass ACR, Crossley B: Mechanisms of human tumor metastasis studied in patients with peritoneoveiious shunts. Cancer Res 44:3584-3592, 1984
57. Weiss L: Principles of Metastasis. Academic Press, Orlando, FL, 1985
58. Weiss L: Metastatic inefficiency: causes and consequences. Cancer Rev 3:1-24, 1986